Clinical Practice Guidelines
Vytra Provider Services offers tools and a wealth of information to
help you better serve your patients.

Quick Login:

  Vytra News:
Seasonal and H1N1 Flu Information and Resources
Information for Members Regarding Timothy's Law
Statement Regarding HIP-GHI Merger

  Popular Links:
Provider Directories
 


 
 
     
  1. Attention Deficit/Hyperactivity Disorder (ADHD)
  2. Alcohol and Other Drugs
  3. AIDS / HIV
  4. Arthritis
  5. Asthma
  6. Bipolar Disorder
  7. Cardiac
  8. COPD
  9. Depression
  10. Diabetes
  11. High Blood Cholesterol
  12. High Blood Pressure
  13. Community Acquired Pneumonia
  14. Prenatal/Postpartum Care
  15. Radiology
  16. Tuberculosis
  17. Disclaimer
Disclaimer These guidelines were approved in February 2006 by the Preventive Health Subcommittee. Guidelines will be reviewed every two years. The ultimate judgment regarding care of a particular patient must be made by the physician and patient in light of circumstances specific to that patient.

 
ADHD Attention Deficit / Hyperactivity Disorder

Summary: The citations address the assessment, diagnosis, and treatment of children, adolescents, and adults who present with symptoms of attention-deficit/hyperactivity disorder.

Diagnostic and Statistical Manual of Mental Disorders , 4 th ed, Text Revision. Arlington, VA: American Psychiatric Press, Inc.; 2000.

Committee on Quality Improvement, Subcommittee on Attention-Deficit/Hyperactivity Disorder. Clinical Practice Guideline: Diagnosis and Evaluation of the Child With Attention-Deficit/Hyperactivity Disorder. Pediatrics 2000;105 (5): 1158-1170.

Committee on Quality Improvement, Subcommittee on Attention-Deficit/Hyperactivity Disorder. Clinical Practice Guideline: Treatment of the School-Aged Child with Attention-Deficit/Hyperactivity Disorder. Pediatrics 2001;108 (4): 1033-1044.

Practice Parameters for the Assessment and Treatment of Children, Adolescents, and Adults with Attention-Deficit/Hyperactivity Disorder . Journal of the American Academy of Child & Adolescent Psychiatry 1997;36(10 Supplement): 85S-121S, October 1997.

Pliszka, SR, Greenhill LL, Crismon ML, et al. The Texas Children's Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Childhood Attention Deficit/Hyperactivity Disorder. Part I:Journal of the American Academy of Child & Adolescent Psychiatry. 39(7):908-919, July 2000

Pliszka, SR, Greenhill LL, Crismon ML, et al. The Texas Children's Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Childhood Attention Deficit/Hyperactivity Disorder. Part II: Tactics. Journal of the American Academy of Child & Adolescent Psychiatry. 39(7):920-927, July 2000.

American Academy of Child and Adolescent Psychiatry. Practice Parameters for the Use of Stimulant Medications in the Treatment of Children, Adolescents, and Adults with Attention-Deficit/Hyperactivity Disorder. J Am Acad Child & Adolesc Psychiatry 2002:41(2suppl): 26S-29S.

Institute for Clinical Systems Improvement. Diagnosis and Management of Attention Deficit Hyperactivity Disorder in Primary Care for School Aged children and Adolescents. Institute for Clinical Systems Improvement (CSI); 2003.

American Academy of Child & Adolescent Psychiatry: Managing Attention-Deficit/Hyperactivity Disorder , Version 2.0, 2004. (Not available on the Web)

TOP  
 
Alcohol and Other Drugs

Alcohol and Other Drug Treatment Guidelines

Summary: The Alcohol and Other Drug Treatment Clinical Practice Guideline were developed as an educational tool for Primary Care Physicians (PCPs), to raise PCP awareness of the disorders. Questions about alcohol and drug use should be included among routine behavioral and lifestyle questions asked of all persons at preventive care visits or as indicated by the PCP.

The Alcohol and Other Drug Treatment Clinical Practice Guideline contains information about the CAGE questionnaire, which is commonly used to screen for alcohol abuse and the CAGE - AID for drug abuse. "CAGE" is an acronym that can be used to remember the questions.

The Alcohol and Other Drug Treatment Clinical Practice Guideline contains information on diagnosis, screening, and treatment options.

TOP  
 
AIDS / HIV

New York State Department of Health AIDS Institute

Background
The site is a collaborative effort between the New York State Department of Health AIDS Institute, Office of the Medical Director and the Johns Hopkins University School of Medicine, Division of Infectious Diseases.

Vision
The web site has been developed as a central, on-line resource that equips individuals who provide services to people with HIV infection with current, state-of-the-art tools to ensure delivery of the highest quality HIV clinical care.

Mission
It is the mission of www.hivguidelines.org to provide clinicians, administrators and policy makers with the necessary information and tools to deliver the highest quality HIV clinical care.

These tools include:

AIDS Institute Office of the Medical Director Clinical Guidelines Program

The AIDS Institute Office of the Medical Director consists of public health professionals dedicated to enhancing the quality of life for persons with HIV by improving prevention and health care services through performance measurement and science-based initiatives. The Office of the Medical Director oversees numerous programs and initiatives including:

  • Clinical Guidelines Program
  • Quality of Care Program
  • Clinical Education Initiative
  • The Nicholas A. Rango HIV Clinical Scholars Program
  • The HIVQUAL Project
  • Education and Training Initiative
  • Treatment Adherence Initiative
  • Materials Initiative

The HIV Clinical Guidelines Program, of which the web site is a product, directly oversees the development, publication and dissemination of state-of-the-art clinical practice guidelines, in collaboration with the Johns Hopkins University - Division of Infectious Diseases. These include guidelines for the medical management of adults, adolescents and children with HIV infection; guidelines in clinical settings; standards of care for oral and mental health of adults and children with HIV/AIDS, and informational brochures for providers and the public. AIDS Institute clinical guidelines are developed by distinguished committees of clinicians and others with extensive experience providing care to people with HIV infection.


Aidsinfo

Summary:AIDSinfo is a U.S. Department of Health and Human Services (DHHS) project that offers the latest federally approved information on HIV/AIDS clinical research, treatment and prevention, and medical practice guidelines for people living with HIV/AIDS, their families and friends, health care providers, scientists, and researchers.

All of the information from the AIDSinfo staff, Web site, and other project resources is from federal government agencies, including the National Institutes of Health, Centers for Disease Control and Prevention (CDC), Health Resources and Services Administration (HRSA) and others. The AIDSinfo project is 100% federally funded. This project neither allows advertising on this site nor endorses any company or products.

Clinical Trials:AIDSinfo offers information on federally and privately funded clinical trials for AIDS patients and others infected with HIV. AIDS clinical trials evaluate experimental drugs and other therapies for adults and children at all stages of HIV infection - from patients who are HIV positive with no symptoms to those with various symptoms of AIDS.

Medical Guidelines:AIDSinfo serves as the main dissemination point for federally approved HIV treatment and prevention guidelines; AIDSinfo provides information about the current treatment regimens for HIV infection and AIDS-related illnesses, including the prevention of HIV transmission from occupational exposure and mother-to-child transmission during pregnancy.

TOP  
 
Arthritis

American College of Rheumatology

Summary: Practice Guidelines developed by the American College of Rheumatology for Rheumatoid Arthritis, Osteoporosis, Osteoarthritis, and other topics including Systemic Lupus Erythematosus in Adults. The Guidelines address treatment options, the critical decisions, and the essential skills and knowledge necessary for optimal patient care.

TOP  
 
Asthma

The Guidelines:

Practical Guide for the Diagnosis and Management of Asthma Based on the Expert Panel Report 2 - Guidelines for the Diagnosis and Management of Asthma (NIH 97-4053) (October 1997). A concise manual emphasizing practical information from the recommendations in the NACPP's 1997 Clinical Practical Guidelines. This concise manual was designed to help the busy primary care provider implement the recommendations in the NAEPP's 1997 clinical practice guidelines. Emphasizing practical information, it outlines key actions clinicians and patients can take to effectively work together in managing asthma. A variety of implementation aids are provided, including medication dosage charts, glossaries of medication brand names, patient self-assessment forms, and several reproducible patient handouts.

National Asthma Education and Prevention Program Expert Panel Report 2 - Guidelines for the Diagnosis and Management of Asthma (NIH Publication No. 97-4051) (July 1997). Updates the 1991 Expert Panel Report. State-of-the-art clinical practice guidelines for diagnosing and managing asthma that update the 1991 expert panel report and incorporate the most recent scientific information available on the care of patients with asthma. Provides information on treating asthma at all severity levels and stresses both clinical and self-management strategies. Also provides a comprehensive discussion of current medications and their appropriate use.

Update 2002: Expert Panel Report

Quick Reference of the NAEPP Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma-Update on Selected Topics 2002. Concise review of timely information on selected priority asthma topics. It summarizes updates to the recommendations of the Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma (1997). (NIH Publication 02-5075; Orig. printed June 2002; Reprinted May 2003. Updates the NAEPP Expert Panel Report 2 (97-4051).

NAEPP Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma-Update on Selected Topics 2002. EPR--Update 2002 provides timely and updated information on several priority asthma topics covered in 1997's Guidelines for the Diagnosis and Management of Asthma. The priority topics addressed include medications, including corticosteroids' role in long term asthma management in children, combination therapy, monitoring and prevention, and modifications to the EPR's Stepwise Approach for Managing Asthma. 2003. (NIH Publication: No. 02-5074 June 2003).

New York State Department of Health Asthma Guidelines

Summary: The website is designed to provide accurate, current and useful information for people with asthma and for the people who care for them. New York State DOH advises that new resources will be added often and the web site should be checked frequently.

Managing Asthma During Pregnancy: Recommendations for Pharmacologic Treatment Update 2004: Quick Reference, Full Report, Evidence Tables.

Summary: Managing Asthma During Pregnancy: Recommendations for Pharmacologic Treatment--Update 2004 updates the Report of the Working Group on Asthma and Pregnancy published by the National Asthma Education and Prevention Program (NAEPP) in 1993. Since then, modification to the general asthma treatment guidelines, Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma (1997) and a subsequent Update 2002 , release of new asthma medications, revisions to the severity classification of asthma, and publication of new gestational safety data were sufficient to warrant an evidence-based update of the 1993 report. In addition, the new guidelines offer recommendations regarding the use of allergy medications in pregnancy based on recent studies of these medications. Information about the expert panel and their financial disclosures is included in the full report.

TOP  
 
Bipolar

Bipolar Disorder

Summary: The Bipolar Disorder Clinical Practice Guideline was developed to complement the Clinical Practice Guideline on Depression and to act as an educational tool for Primary Care Physicians (PCPs), who suspect Bipolar Disorder. The CPG reiterates that PCPs should refer all cases of Bipolar Disorder to a Mental Health Practitioner.

Bipolar Disorder is more prevalent than previously thought and can easily be overlooked or misdiagnosed. As per the American Psychiatric Association (APA), the prevalence rates in the general population for Bipolar I (Mania) is 0.08% and Bipolar II (Depression) 0.05%. One of the reasons for misdiagnosis is that people with Bipolar Disorder rarely volunteer information about manic or hypomanic episodes.

The Bipolar Disorder Clinical Practice Guideline includes a validated mood disorder-screening tool - Mood Disorder Questionnaire (MDQ) that can be administered either by the PCP or self-administered by the patient. The Bipolar Disorder Clinical Practice Guideline contains information on screening, diagnosis, treatment, co-morbidity, and psychosocial treatment.

TOP  
 
Cardiac

ACC/AHA Joint Guidelines

Summary: Clinical practice guidelines, written jointly by the American Heart Association and the American College of Cardiology (ACC) —suggest appropriate use of diagnostic procedures, therapeutic interventions, and/or therapies in managing cardiovascular diseases.  

Mycardial Infarction

ACC/AHA Clinical Performance Measures for Adults With ST-Elevation and Non-ST Elevation Myocardial Infarction. A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (2006)

Summary: This Guideline focuses on the development of performance measures concerning the diagnosis and treatment of both ST-Elevation Myocardial Infarction (STEMI) and Non-ST-Elevation Myocardial Infarction (NSTEMI).

AHA Scientific Statement: Practical Implementation of the Guidelines for Unstable Angina/Non-ST-Segment Elevation Myocardial Infarction in the Emergency Department

Summary: This update of the 2002 American College of Cardiology/American Heart Association Guidelines for the Management of Patients with Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction (UA/NSTEMI) provides an evidence-based approach to the diagnosis and treatment of these patients in the emergency department, in-hospital, and after hospital discharge.

Angina

ACC/AHA 2002 Guideline Update for the Management of Patients with Chronic Stable Angina - Full Text, Summary Article

Summary: The primary focus of this guideline is on symptomatic patients; asymptomatic patients with known or suspected coronary disease are included in this update.

Heart Failure

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult - Full Text, Summary Article

Summary: Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure)

ACC/AHA Key Data Elements and Definitions for Measuring the Clinical Management and Outcomes of Patients With Chronic Heart Failure.

Summary: The American College of Cardiology (ACC) and the American Heart Association (AHA hope that these clinical data standards will:

  • Improve cross-comparison of results and clinical outcomes between different trials and registries.
  • Facilitate the development and conduct of future registries, at both hospital and national levels, by providing a list of major variables, outcomes, and definitions.
  • Facilitate measurement for quality improvement programs.
  • Become the basis for a standardized medical documentation process with the anticipation that the medical record will progress to an electronic format.

ACC/AHA Clinical Performance Measures for Adults With Chronic Heart Failure.

Summary: The ACC/AHA Heart Failure Performance Measures for Adults With Chronic Heart Failure.

TOP  
 
COPD

Chronic Obstructive Pulmonary Disease (COPD)

American American Thoracic Society: Dyspnea Mechanisms Assessment, and Management: A Consensus Statement (1998)

Summary: Provides an understanding of dyspnea, including its physiologic bases, methods of assessment, and management strategies.

American American Thoracic Society: Standards for Diagnosis and Care of Patients with Chronic Obstructive Pulmonary Disease (1995)

Summary: Contents include epidemiology, pathophysiology, staging, outpatient management, inpatient management, surgery, and ethical issues.

GOLD(Global Initiative for Chronic Obstructive Lung Disease)             Practitioner Resources
    • Workshop Report, Global Strategy for Diagnosis, Management, and Prevention of COPD. Updated 2005
    • Executive Summary, Global Strategy for the Diagnosis, Management, and Prevention of COPD. Updated 2005.
    • Pocket Guide to COPD Diagnosis, Management, and Prevention. Updated 2005.
    • Spirometry for Diagnosis of COPD: Insert for GOLD Pocket Guide (July 2003)
    • At-A-Glance Outpatient COPD Management Reference (January 2005)
            Patient Guides
    • GOLD Patient Guide: What You and Your Family Can Do About COPD. (NIH Publication No. 02-2701C, May 2002)

Summary: The Global Initiative for Chronic Obstructive Lung Disease (GOLD) works with health care professionals and public health officials around the world to raise awareness of Chronic Obstructive Pulmonary Disease (COPD) and to improve prevention and treatment of this lung disease.

Through the development of evidence-based guidelines for COPD management, and events such as the annual celebration of World COPD Day, GOLD is working to improve the lives of people with COPD in every corner of the globe.

TOP  
 
Depression

Practice Guideline for the Treatment of Patients With Major Depressive Disorder, Second Edition

Treating Major Depressive Disorder - A Quick Reference Guide

Treatment Works - Major Depressive Disorder - A Patient and Family Guide

Summary: The American Psychiatric Association (APA) practice guidelines are intended to assist psychiatrists in clinical decision-making and to improve patient care. They also document evidence available to determine appropriate care. A practice guideline is not a "standard of care." The ultimate judgment regarding a particular clinical procedure or treatment plan must be made by the psychiatrist in light of the clinical data presented by the patient and the diagnostic and treatment options available.

TOP  
 
Diabetes

American Diabetes Association (ADA)

Summary: The ADA Clinical Practice Guidelines are based on a complete review of the relevant literature by a diverse group of highly trained clinicians. After weighing the quality of evidence, from rigorous double-blind clinical trials to expert opinion, recommendations are drafted, reviewed, and submitted for approval to the ADA Executive Committee; they are then revised on a regular basis, and subsequently published in Diabetes Care.

Beginning with the 2005 supplement, the Clinical Practice Recommendations contained only the "Standards of Medical Care in Diabetes" and selected other Position Statements. Per the ADA, this change was made to emphasize the importance of the "Standards" s the best source to determine ADA recommendations. The Position Statements in the Supplement are updated yearly. Position Statements not included in the Supplement, as per the ADA, will be updated as necessary and republished when complete.

TOP  
 
High Blood Cholesterol

Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)

Summary: The ATP III guidelines provide detailed information on topic areas such as classification of lipids and lipoproteins, coronary heart disease (CHD) risk assessment, lifestyle interventions, drug treatment, specific dyslipidemias, and adherence issues. Recommendations for special populations such as patients with CHD, patients at high risk for developing CHD, patients with diabetes, women, older Americans, young adults, and racial and ethnic groups are provided. (Available as Executive Summary and Full Report)

ATP III Update 2004: Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines

Summary: The Adult Treatment Panel III (ATP III) of the National Cholesterol Education Program issued an evidence-based set of guidelines on cholesterol management in 2001 (Executive Summary published in JAMA, 2001;285:2486-2497). Since the publication of ATP III, 5 major clinical trials of statin therapy with clinical end points have been published. These trials addressed issues that were not examined in previous clinical trials of cholesterol-lowering therapy. The present document reviews the results of these recent trials and assesses their implications for cholesterol management. Circulation. 2004;110:227-239.

ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins

Summary: This American College of Cardiology/ American Heart Association/National Heart, Lung and Blood Institute (ACC/AHA/NHLBI) Clinical Advisory summarizes the current understanding of statin use, focused on myopathy, and to provide updated recommendations for the appropriate use of statins, including cautions, contraindications, and safety monitoring for statin therapy. Included in the Advisory is recent myopathy information compiled by the FDA, information from clinical trials, and summaries from the recently released report of the Adult Treatment Panel III (ATP III) of the National Cholesterol Education Program.

Diagnosis and Management of the Metabolic Syndrome - An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement: Executive Summary, Full Text

Summary: Metabolic syndrome has received increased attention in the past few years. This statement from the American Heart Association (AHA) and the National Heart, Lung, and Blood Institute (NHLBI) is intended to provide up-to-date guidance for professionals on the diagnosis and management of the metabolic syndrome in adults.

TOP  
 
High Blood Pressure

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7)

Summary: The “Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure” provides a new guideline for hypertension prevention and management. (Available JNC 7 Express and Full Report)

The Fourth Report on the Diagnosis, Evaluation, and Treatment of High blood Pressure in Children and Adolescents. August 2004

Summary: Development of a large national database on normative BP levels throughout childhood, the ability to identify children who have abnormally elevated BP has improved. It is now apparent that primary hypertension is detectable in the young and occurs commonly. Long-term health risks for hypertensive children and adol. Can be substantial; therefore, it is important that clinical measures be taken to reduce these risks and optimize health outcomes. This Report updates clinicians on the latest scientific evidence regarding BP in children and provides recommendations for diagnosis, evaluation, and treatment of hypertension.

TOP  
 
Pneumonia

Community-Acquired Pneumonia in Adults

Halm, Ethan, and Alvin S. Teirstein. "Management of Community-Acquired Pneumonia." New England Journal of Medicine Vol. 347, No 25, December 19, 2002.

Summary: The article begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they exist. The article ends with the authors' clinical recommendations.

Degelau, John MD, Work Group Leader. "Health care Guideline: Community-Acquired Pneumonia in Adults." Institute For Clinical Systems Improvement, May 2005.

Summary: To provide recommendations for the diagnosis and treatment of community-acquired pneumonia in patients 16 years of age and older. This document also provides recommendations for outpatient management and indications for hospitalization, taking into consideration ongoing changes in antibiotic resistance. This guideline excludes patients with HIV infection and pneumonia in immunocompromised patients.

TOP  
 
Prenatal / Postpartum Care

Prenatal / Postpartum Clinical Practice Guidelines

Summary: The goal of prenatal and postpartum care is to optimize the health of the mother as well as that of the fetus and newborn. Prenatal care includes a comprehensive history, genetic screening/tetatology counseling, physical examination, laboratory tests, risk, nutrition, and psychosocial assessments as well as counseling. The American College of Obstetrics and Gynecology (ACOG) strongly encourages pregnant females to schedule an appointment with her OB/GYN before the 12 th week of pregnancy. Prenatal care is then recommended every four (4) weeks up to 28 weeks; every 2 weeks until 36 weeks; and weekly after 36 weeks. A postpartum visit is strongly encouraged 21 to 56 days after delivery and includes details of the delivery, physical examination, laboratory tests, and counseling. Counseling should include, but is not limited to breast-feeding, postpartum depression, contraceptive methods, future health and pregnancies.
TOP  
 
Radiology

ACR Practices Guidelines and Technical Standards

Summary: The American College of Radiology (ACR) Practice Guidelines and Technical Standards define principles and technical parameters of radiologic and radiation oncology practice designed to provide consensus-based scientifically valid and medically credible information to assist health care providers in delivering effective, efficient, consistent and safe medical care.

TOP  
 
Tuberculosis

Treatment of Tuberculosis: American Thoracic Society, CDC, and Infectious Diseases Society of America. (June 20, 2003/52 (RR11); 1-77)

Summary: : The recommendations in this document are intended to guide the treatment of tuberculosis in settings where mycobacterial cultures, drug susceptibility testing, radiographic facilities, and second-line drugs are routinely available. In areas where these resources are not available, the recommendations provided by the World Health Organization, the International Union against Tuberculosis, or national tuberculosis control programs should be followed.

Erratum - (January 7, 2005/53(51&52; 1203)

Summary: : In the MMWR Recommendations and Reports, "Treatment of Tuberculosis: American Thoracic Society, CDC, and Infectious Diseases Society of America," two errors occurred. In Table 3 (pages 4--5), the subheading of the second column under "Doses" should read, "1x/wk." On page 25, column 2, in section 3.2.1 Cycloserine, the adult dosage should read, "Serum concentration measurements aiming for a peak concentration of 20--35 mg/l are often useful in determining the optimum dose for a given patient."

Update - Adverse Event Data and Revised American Thoracic Society/CDC Recommendations Against the Use of Rifampin and Pyrazinamide for Treatment of Latent Tuberculosis Infection---United States, 2003 (August 8, 2003/52 (31); 735-739)

Trends in Tuberculosis - United States, 1998-2003 (March 19, 2004/53(10); 209-214)

Summary: : Center for Disease Control and Prevention Morbidity and Mortality Weekly Reports addressing the trends in tuberculosis for the United States, 1998-2003 and recommendations for the treatment of tuberculosis.

Erratum - (March 26, 2004 / 53(11);246) (use same web link as in Trends as the link for the Erratum is in that article)

Summary: : In the report, "Trends in Tuberculosis---United States, 1998--2003," on page 212, the last sentence of the sixth paragraph of the report should read, "Among U.S.-born persons in 2003, the non-Hispanic black population had the largest number of TB cases (3,041 cases, 45.0%)."

National Center for HIV, STD and TB Prevention - Division of Tuberculosis Elimination: TB Guidelines

Summary: : The mission of the Division of Tuberculosis Elimination (DTBE) is to promote health and quality of life by preventing, controlling, and eventually eliminating tuberculosis from the United States, and by collaborating with other countries and international partners in controlling tuberculosis world-wide.

TOP  
 
 
TOP  
Disclaimer These guidelines were approved in February 2006 by the Preventive Health Subcommittee. Guidelines will be reviewed every two years. The ultimate judgment regarding care of a particular patient must be made by the physician and patient in light of circumstances specific to that patient.
 
 
About Vytra
Urgent Care
Privacy Policy